Showing results (51-60 of 651) with videos related to
Sort By:
Pageof 66
Diabetes Care|April 2, 2010
Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathyMaria Lajer, Anders Jorsal, Lise Tarnow, et al.Blood Pressure Monitoring|April 3, 2013
Tonometric devices for central aortic systolic pressure measurements in patients with type 1 diabetes: comparison of the BPro and SphygmoCor devicesSimone Theilade, Tine W Hansen, Christel Joergensen, et al.Acta Diabetologica|October 3, 2014
Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffnessSigne Rosenlund, Simone Theilade, Tine Willum Hansen, et al.Diabetes, Obesity & Metabolism|March 12, 2026
Cardio-Kidney-Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney DiseaseM Luiza Caramori, Enrico Repetto, Christopher Perkins, et al.Diabetes Care|April 29, 2011
Vitamin D levels, microvascular complications, and mortality in type 1 diabetesChristel Joergensen, Peter Hovind, Anne Schmedes, et al.Journal of Diabetes and Its Complications|July 15, 2022
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk enginesElisabeth B Stougaard, Peter Rossing, David Cherney, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2002
Optimal dose of losartan for renoprotection in diabetic nephropathySteen Andersen, Peter Rossing, Tina R Juhl, et al.Diabetes|May 5, 2009
Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort studyPeter Hovind, Peter Rossing, Lise Tarnow, et al.Ugeskrift for Laeger|October 2, 2013
[Clinical use of estimated glomerular filtration rate for evaluation of kidney function]Bo Broberg, Morten Lindhardt, Peter Rossing, et al.Diabetes, Obesity & Metabolism|November 6, 2024
The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney diseaseJohannes David Smeijer, Maria F Gomez, Peter Rossing, et al.Pageof 66